Dr. Suthep Wongpat Dr. Suthep Wongpat, former director responsible for the operation of the company under the Securities Exchange Act B.E. 2535 (1992) and entrusted to manage the property of the
violated Section 98(8) of the Securities and Exchange Act B.E. 2535 amended by the Securities and Exchange Act (No. 5) B.E. 2559. SEC Act S.283 Settlement Committee Meeting No. 5/2024 Settlement Committee
the period as specified by the Securities and Exchange Commission (Bill of exchange sell closing date : October 5, 2021 to January 27, 2022) SEC Act S.64 paragraph 2 Settlement Committee Meeting No
the period as specified by the Securities and Exchange Commission (Bill of exchange sell closing date : October 5, 2021 to November 4, 2021) SEC Act S.64 paragraph 2 Settlement Committee Meeting No
to order or act resulting in Beyond’s failure to put in place sufficient and effective risk management system which violated Section 113 of the Securities and Exchange Act B.E. 2535 amended by the
of panic redemption, especially crisis communication plan which violated section 117 of the Securities and Exchange Act B.E. 2535 amended by the Securities and Exchange Act (No. 4) B.E. 2551. SEC
S D Global S D Global operated securities business without obtaining license from the SEC, in violation of the Securities and Exchange Act B.E. 2535 (1992), Section 90 and subject to sanctions under
Seandar Inc. Seandar Inc. (or Seandar) operated securities business without obtaining license from the SEC, in violation of the Securities and Exchange Act B.E. 2535 (1992), Section 90 and subject to
breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 2/2022 Settlement Committee Order No. 44/2022 Dated 28/02/2022
breach of the Securities and Exchange Act B.E. 2535. SEC Act S.33 Settlement Committee Meeting No. 5/2022 Settlement Committee Order No. 70/2022 Dated 05/05/2022